BRIM is a clinical-stage company developing novel peptide treatments for hard-to-treat diseases. BRIM’s first-in-class assets are based on its innovative stem cell regenerative PDSP technology platform, which has the potential to be effective in multiple therapy areas and indications.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 8f, No. 1, Alley 30, Lane 358, Ruiguang Rd., Neihu District, Taipei City,taiwan 114,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.brimbiotech.com/en/
- HQ
- Taipei City, Taiwan
Brim Biotechnology, Inc. Questions
Brim Biotechnology, Inc.'s website is https://www.brimbiotech.com/en/
Brim Biotechnology, Inc.'s LinkedIn profile is https://tw.linkedin.com/company/brimbiotech
Brim Biotechnology, Inc. has
17 employees.
View email and phone details for 17
employees at Brim Biotechnology, Inc..
Brim Biotechnology, Inc.'s industry is
Biotechnology Research
Brim Biotechnology, Inc.'s top competitors are
Coherence Bio,
宏虹電子科技有限公司 Honghong Technology Co.,ltd. (Taiwan Hongke),
Perfuse Therapeutics,
Catapult Therapeutics,
Locus Cell Co., Ltd,
Allianz Pharmascience Ltd.,
Alpha Plus 最 Dei 的夥伴,
創生醫電 Plasmonictron,
Bausch + Lomb,
Topmunnity Therapeutics Limited.
Brim Biotechnology, Inc.'s categories are Biotechnology Research
Brim Biotechnology, Inc.'s founding year is 2013
